UniProt ID | DDX3X_MOUSE | |
---|---|---|
UniProt AC | Q62167 | |
Protein Name | ATP-dependent RNA helicase DDX3X | |
Gene Name | Ddx3x | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 662 | |
Subcellular Localization | Nucleus speckle. Cytoplasm. Mitochondrion outer membrane. Located predominantly in nuclear speckles and, at low levels, throughout the cytoplasm. Located to the outer side of nuclear pore complexes (NPC). Shuttles between the nucleus and the cytoplas | |
Protein Description | Multifunctional ATP-dependent RNA helicase. The ATPase activity can be stimulated by various ribo- and deoxynucleic acids indicative for a relaxed substrate specificity. In vitro can unwind partially double-stranded DNA with a preference for 5'-single-stranded DNA overhangs. Is involved in several steps of gene expression, such as transcription, mRNA maturation, mRNA export and translation. However, the exact mechanisms are not known and some functions may be specific for a subset of mRNAs. Involved in transcriptional regulation. Can enhance transcription from the CDKN1A/WAF1 promoter in a SP1-dependent manner. Found associated with the E-cadherin promoter and can down-regulate transcription from the promoter. Involved in regulation of translation initiation. Proposed to be involved in positive regulation of translation such as of cyclin E1/CCNE1 mRNA and specifically of mRNAs containing complex secondary structures in their 5'UTRs; these functions seem to require RNA helicase activity. Specifically promotes translation of a subset of viral and cellular mRNAs carrying a 5'proximal stem-loop structure in their 5'UTRs and cooperates with the eIF4F complex. Proposed to act prior to 43S ribosomal scanning and to locally destabilize these RNA structures to allow recognition of the mRNA cap or loading onto the 40S subunit. After association with 40S ribosomal subunits seems to be involved in the functional assembly of 80S ribosomes; the function seems to cover translation of mRNAs with structured and non-structured 5'UTRs and is independent of RNA helicase activity. Also proposed to inhibit cap-dependent translation by competetive interaction with EIF4E which can block the EIF4E:EIF4G complex formation. Proposed to be involved in stress response and stress granule assembly; the function is independent of RNA helicase activity and seems to involve association with EIF4E. May be involved in nuclear export of specific mRNAs but not in bulk mRNA export via interactions with XPO1 and NXF1. Also associates with polyadenylated mRNAs independently of NXF1. Associates with spliced mRNAs in an exon junction complex (EJC)-dependent manner and seems not to be directly involved in splicing. May be involved in nuclear mRNA export by association with DDX5 and regulating its nuclear location. Involved in innate immune signaling promoting the production of type I interferon (IFN-alpha and IFN-beta); proposed to act as viral RNA sensor, signaling intermediate and transcriptional coactivator. Involved in TBK1 and IKBKE-dependent IRF3 activation leading to IFNB induction, plays a role of scaffolding adapter that links IKBKE and IRF3 and coordinates their activation. Also found associated with IFNB promoters; the function is independent of IRF3. Can bind to viral RNAs and via association with MAVS/IPS1 and DDX58/RIG-I is thought to induce signaling in early stages of infection. Involved in regulation of apoptosis. May be required for activation of the intrinsic but inhibit activation of the extrinsic apoptotic pathway. Acts as an antiapoptotic protein through association with GSK3A/B and BIRC2 in an apoptosis antagonizing signaling complex; activation of death receptors promotes caspase-dependent cleavage of BIRC2 and DDX3X and relieves the inhibition. May be involved in mitotic chromosome segregation. Is an allosteric activator of CSNK1E, it stimulates CSNK1E-mediated phosphorylation of DVL2 and is involved in the positive regulation of canonical Wnt signaling (By similarity).. | |
Protein Sequence | MSHVAVENALGLDQQFAGLDLNSSDNQSGGSTASKGRYIPPHLRNREATKGFYDKDSSGWSSSKDKDAYSSFGSRGDSRGKSSFFGDRGSGSRGRFDDRGRGDYDGIGGRGDRSGFGKFERGGNSRWCDKSDEDDWSKPLPPSERLEQELFSGGNTGINFEKYDDIPVEATGNNCPPHIESFSDVEMGEIIMGNIELTRYTRPTPVQKHAIPIIKEKRDLMACAQTGSGKTAAFLLPILSQIYADGPGEALRAMKENGRYGRRKQYPISLVLAPTRELAVQIYEEARKFSYRSRVRPCVVYGGAEIGQQIRDLERGCHLLVATPGRLVDMMERGKIGLDFCKYLVLDEADRMLDMGFEPQIRRIVEQDTMPPKGVRHTMMFSATFPKEIQMLARDFLDEYIFLAVGRVGSTSENITQKVVWVEEIDKRSFLLDLLNATGKDSLTLVFVETKKGADSLEDFLYHEGYACTSIHGDRSQRDREEALHQFRSGKSPILVATAVAARGLDISNVKHVINFDLPSDIEEYVHRIGRTGRVGNLGLATSFFNERNINITKDLLDLLVEAKQEVPSWLENMAFEHHYKGSSRGRSKSSRFSGGFGARDYRQSSGASSSSFSSSRASSSRSGGGGHGGSRGFGGGGYGGFYNSDGYGGNYNSQGVDWWGN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSHVAVENA ------CCCHHHHCC | 27.03 | 10859333 | |
2 | Phosphorylation | ------MSHVAVENA ------CCCHHHHCC | 27.03 | 29514104 | |
23 | Phosphorylation | FAGLDLNSSDNQSGG HCCCCCCCCCCCCCC | 46.49 | 26824392 | |
24 | Phosphorylation | AGLDLNSSDNQSGGS CCCCCCCCCCCCCCC | 39.24 | 26643407 | |
28 | Phosphorylation | LNSSDNQSGGSTASK CCCCCCCCCCCCCCC | 51.91 | 26643407 | |
31 | Phosphorylation | SDNQSGGSTASKGRY CCCCCCCCCCCCCCC | 25.07 | 26643407 | |
32 | Phosphorylation | DNQSGGSTASKGRYI CCCCCCCCCCCCCCC | 37.92 | 26643407 | |
34 | Phosphorylation | QSGGSTASKGRYIPP CCCCCCCCCCCCCCH | 35.41 | 26643407 | |
50 | Acetylation | LRNREATKGFYDKDS HCCCHHHCCCCCCCC | 54.81 | 22902405 | |
53 | Phosphorylation | REATKGFYDKDSSGW CHHHCCCCCCCCCCC | 30.65 | 22817900 | |
55 | Acetylation | ATKGFYDKDSSGWSS HHCCCCCCCCCCCCC | 48.40 | 23806337 | |
57 | Phosphorylation | KGFYDKDSSGWSSSK CCCCCCCCCCCCCCC | 36.17 | 29899451 | |
61 | Phosphorylation | DKDSSGWSSSKDKDA CCCCCCCCCCCCHHH | 28.41 | 26745281 | |
62 | Phosphorylation | KDSSGWSSSKDKDAY CCCCCCCCCCCHHHH | 34.59 | 26745281 | |
63 | Phosphorylation | DSSGWSSSKDKDAYS CCCCCCCCCCHHHHH | 39.08 | 29899451 | |
66 | Malonylation | GWSSSKDKDAYSSFG CCCCCCCHHHHHHCC | 48.25 | 26320211 | |
69 | Phosphorylation | SSKDKDAYSSFGSRG CCCCHHHHHHCCCCC | 18.25 | 20116462 | |
70 | Phosphorylation | SKDKDAYSSFGSRGD CCCHHHHHHCCCCCC | 22.40 | 25159016 | |
71 | Phosphorylation | KDKDAYSSFGSRGDS CCHHHHHHCCCCCCC | 22.43 | 26824392 | |
74 | Phosphorylation | DAYSSFGSRGDSRGK HHHHHCCCCCCCCCC | 30.95 | 23684622 | |
78 | Phosphorylation | SFGSRGDSRGKSSFF HCCCCCCCCCCCCCC | 45.84 | 25266776 | |
81 | Ubiquitination | SRGDSRGKSSFFGDR CCCCCCCCCCCCCCC | 41.64 | - | |
82 | Phosphorylation | RGDSRGKSSFFGDRG CCCCCCCCCCCCCCC | 34.89 | 27087446 | |
83 | Phosphorylation | GDSRGKSSFFGDRGS CCCCCCCCCCCCCCC | 28.25 | 26824392 | |
88 | Methylation | KSSFFGDRGSGSRGR CCCCCCCCCCCCCCC | 41.37 | - | |
90 | Phosphorylation | SFFGDRGSGSRGRFD CCCCCCCCCCCCCCC | 34.19 | 27087446 | |
92 | Phosphorylation | FGDRGSGSRGRFDDR CCCCCCCCCCCCCCC | 33.00 | 27087446 | |
93 | Dimethylation | GDRGSGSRGRFDDRG CCCCCCCCCCCCCCC | 43.78 | - | |
93 | Methylation | GDRGSGSRGRFDDRG CCCCCCCCCCCCCCC | 43.78 | - | |
95 | Methylation | RGSGSRGRFDDRGRG CCCCCCCCCCCCCCC | 30.61 | - | |
101 | Methylation | GRFDDRGRGDYDGIG CCCCCCCCCCCCCCC | 35.39 | 24129315 | |
104 | Phosphorylation | DDRGRGDYDGIGGRG CCCCCCCCCCCCCCC | 20.92 | 16873679 | |
110 | Methylation | DYDGIGGRGDRSGFG CCCCCCCCCCCCCCC | 38.33 | 24129315 | |
113 | Methylation | GIGGRGDRSGFGKFE CCCCCCCCCCCCCCC | 41.31 | - | |
114 | Phosphorylation | IGGRGDRSGFGKFER CCCCCCCCCCCCCCC | 43.12 | - | |
118 | Ubiquitination | GDRSGFGKFERGGNS CCCCCCCCCCCCCCC | 41.62 | - | |
118 | Acetylation | GDRSGFGKFERGGNS CCCCCCCCCCCCCCC | 41.62 | - | |
128 | Glutathionylation | RGGNSRWCDKSDEDD CCCCCCCCCCCCCCC | 4.60 | 24333276 | |
130 | Acetylation | GNSRWCDKSDEDDWS CCCCCCCCCCCCCCC | 57.58 | 23806337 | |
131 | Phosphorylation | NSRWCDKSDEDDWSK CCCCCCCCCCCCCCC | 32.74 | 26643407 | |
152 | Phosphorylation | RLEQELFSGGNTGIN HHHHHHHCCCCCCCC | 59.42 | 29514104 | |
183 | Phosphorylation | PPHIESFSDVEMGEI CCCCCCCCCCCCCEE | 50.45 | - | |
200 | Phosphorylation | GNIELTRYTRPTPVQ EEEEEEEECCCCCCH | 11.23 | 29514104 | |
215 | Ubiquitination | KHAIPIIKEKRDLMA HCCCHHHHCHHCHHH | 58.88 | - | |
223 | S-nitrosocysteine | EKRDLMACAQTGSGK CHHCHHHHHHCCCCH | 1.47 | - | |
223 | S-nitrosylation | EKRDLMACAQTGSGK CHHCHHHHHHCCCCH | 1.47 | 20925432 | |
223 | S-palmitoylation | EKRDLMACAQTGSGK CHHCHHHHHHCCCCH | 1.47 | 28526873 | |
226 | Phosphorylation | DLMACAQTGSGKTAA CHHHHHHCCCCHHHH | 18.13 | 24759943 | |
228 | Phosphorylation | MACAQTGSGKTAAFL HHHHHCCCCHHHHHH | 40.27 | 24759943 | |
240 | Phosphorylation | AFLLPILSQIYADGP HHHHHHHHHHHCCCC | 18.43 | 28059163 | |
243 | Phosphorylation | LPILSQIYADGPGEA HHHHHHHHCCCCHHH | 7.33 | 22817900 | |
264 | Ubiquitination | NGRYGRRKQYPISLV HCCCCCCCCCCCEEE | 53.47 | - | |
266 | Phosphorylation | RYGRRKQYPISLVLA CCCCCCCCCCEEEEC | 12.93 | 29514104 | |
283 | Phosphorylation | RELAVQIYEEARKFS HHHHHHHHHHHHHCC | 7.22 | 22817900 | |
293 | Phosphorylation | ARKFSYRSRVRPCVV HHHCCHHHCCCCEEE | 27.22 | - | |
298 | S-nitrosocysteine | YRSRVRPCVVYGGAE HHHCCCCEEEECCHH | 1.96 | - | |
298 | S-palmitoylation | YRSRVRPCVVYGGAE HHHCCCCEEEECCHH | 1.96 | 28526873 | |
298 | S-nitrosylation | YRSRVRPCVVYGGAE HHHCCCCEEEECCHH | 1.96 | 20925432 | |
301 | Phosphorylation | RVRPCVVYGGAEIGQ CCCCEEEECCHHHHH | 6.88 | 22817900 | |
317 | S-nitrosocysteine | IRDLERGCHLLVATP HHHHHCCCEEEEECC | 2.27 | - | |
317 | S-palmitoylation | IRDLERGCHLLVATP HHHHHCCCEEEEECC | 2.27 | 28526873 | |
317 | S-nitrosylation | IRDLERGCHLLVATP HHHHHCCCEEEEECC | 2.27 | 20925432 | |
323 | Phosphorylation | GCHLLVATPGRLVDM CCEEEEECCCHHHHH | 20.85 | 26824392 | |
335 | Ubiquitination | VDMMERGKIGLDFCK HHHHHCCCCCHHHHH | 39.56 | - | |
335 | Malonylation | VDMMERGKIGLDFCK HHHHHCCCCCHHHHH | 39.56 | 26320211 | |
410 | Phosphorylation | LAVGRVGSTSENITQ HHCCCCCCCCCCCCE | 26.38 | 30635358 | |
411 | Phosphorylation | AVGRVGSTSENITQK HCCCCCCCCCCCCEE | 33.85 | 26745281 | |
412 | Phosphorylation | VGRVGSTSENITQKV CCCCCCCCCCCCEEE | 30.28 | 29176673 | |
456 | Phosphorylation | ETKKGADSLEDFLYH EECCCCCCHHHHHHC | 32.88 | 22817900 | |
462 | Phosphorylation | DSLEDFLYHEGYACT CCHHHHHHCCCCCCC | 9.60 | 22817900 | |
466 | Phosphorylation | DFLYHEGYACTSIHG HHHHCCCCCCCCCCC | 8.77 | 18034455 | |
468 | S-nitrosocysteine | LYHEGYACTSIHGDR HHCCCCCCCCCCCCC | 2.00 | - | |
468 | S-nitrosylation | LYHEGYACTSIHGDR HHCCCCCCCCCCCCC | 2.00 | 20925432 | |
508 | Phosphorylation | AARGLDISNVKHVIN HHCCCCCCCCEEEEE | 34.93 | 22006019 | |
511 | Ubiquitination | GLDISNVKHVINFDL CCCCCCCEEEEECCC | 36.08 | - | |
520 | Phosphorylation | VINFDLPSDIEEYVH EEECCCCCCHHHHHH | 59.52 | 26745281 | |
525 | Phosphorylation | LPSDIEEYVHRIGRT CCCCHHHHHHHHCCC | 6.70 | 26745281 | |
554 | Ubiquitination | ERNINITKDLLDLLV CCCCCCCHHHHHHHH | 42.45 | - | |
580 | Phosphorylation | NMAFEHHYKGSSRGR HHHHHHCCCCCCCCC | 20.96 | 29514104 | |
583 | Phosphorylation | FEHHYKGSSRGRSKS HHHCCCCCCCCCCCC | 16.83 | 27600695 | |
588 | Phosphorylation | KGSSRGRSKSSRFSG CCCCCCCCCCCCCCC | 39.45 | 29514104 | |
590 | Phosphorylation | SSRGRSKSSRFSGGF CCCCCCCCCCCCCCC | 28.17 | 27087446 | |
591 | Phosphorylation | SRGRSKSSRFSGGFG CCCCCCCCCCCCCCC | 40.87 | 27600695 | |
592 | Dimethylation | RGRSKSSRFSGGFGA CCCCCCCCCCCCCCC | 36.52 | - | |
592 | Methylation | RGRSKSSRFSGGFGA CCCCCCCCCCCCCCC | 36.52 | - | |
594 | Phosphorylation | RSKSSRFSGGFGARD CCCCCCCCCCCCCCC | 36.58 | 27087446 | |
602 | Phosphorylation | GGFGARDYRQSSGAS CCCCCCCHHCCCCCC | 12.66 | 29899451 | |
605 | Phosphorylation | GARDYRQSSGASSSS CCCCHHCCCCCCCCC | 23.03 | 25521595 | |
606 | Phosphorylation | ARDYRQSSGASSSSF CCCHHCCCCCCCCCC | 30.00 | 25521595 | |
609 | Phosphorylation | YRQSSGASSSSFSSS HHCCCCCCCCCCCCC | 33.99 | 25521595 | |
610 | Phosphorylation | RQSSGASSSSFSSSR HCCCCCCCCCCCCCC | 29.48 | 30635358 | |
611 | Phosphorylation | QSSGASSSSFSSSRA CCCCCCCCCCCCCCC | 32.67 | 30635358 | |
612 | Phosphorylation | SSGASSSSFSSSRAS CCCCCCCCCCCCCCC | 30.97 | 25521595 | |
614 | Phosphorylation | GASSSSFSSSRASSS CCCCCCCCCCCCCCC | 29.38 | 29472430 | |
615 | Phosphorylation | ASSSSFSSSRASSSR CCCCCCCCCCCCCCC | 23.10 | 23984901 | |
616 | Phosphorylation | SSSSFSSSRASSSRS CCCCCCCCCCCCCCC | 30.57 | 23984901 | |
617 | Methylation | SSSFSSSRASSSRSG CCCCCCCCCCCCCCC | 40.20 | - | |
619 | Phosphorylation | SFSSSRASSSRSGGG CCCCCCCCCCCCCCC | 27.95 | 27149854 | |
621 | Phosphorylation | SSSRASSSRSGGGGH CCCCCCCCCCCCCCC | 28.15 | 29899451 | |
632 | Methylation | GGGHGGSRGFGGGGY CCCCCCCCCCCCCCC | 47.97 | 24129315 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DDX3X_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DDX3X_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DDX3X_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of DDX3X_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"An N-acetylated natural ligand of human histocompatibility leukocyteantigen (HLA)-B39. Classical major histocompatibility complex class Iproteins bind peptides with a blocked NH(2) terminus in vivo."; Yaguee J., Alvarez I., Rognan D., Ramos M., Vazquez J.,Lopez de Castro J.A.; J. Exp. Med. 191:2083-2092(2000). Cited for: PROTEIN SEQUENCE OF 2-10, AND ACETYLATION AT SER-2. | |
Phosphorylation | |
Reference | PubMed |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-594, AND MASSSPECTROMETRY. | |
"Identification of phosphoproteins and their phosphorylation sites inthe WEHI-231 B lymphoma cell line."; Shu H., Chen S., Bi Q., Mumby M., Brekken D.L.; Mol. Cell. Proteomics 3:279-286(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74, AND MASSSPECTROMETRY. |